Insights into Flow and Continuous Systems in Pharmaceutical Manufacturing: Challenges and Opportunities

Ireland’s pharmaceutical sector has evolved from a primarily API‑focused manufacturing base into a globally integrated ecosystem spanning process R&D, formulation, bioprocessing, and advanced biotechnology. This expansion has been driven by deep regulatory trust and a strong talent pipeline, enabling Ireland to play a central role in global supply chains.

In recent years, the shift toward continuous flow technology has marked a major inflection point, offering gains in safety, efficiency, and flexibility. With multinational sites, CDMOs, and indigenous innovators working closely with regulators, Ireland has successfully embedded flow chemistry at commercial scale.

Explore the full resource to dive deeper into how this transformation is shaping the future of API and RSM manufacture.